Delta Air Lines Inc. (0QZ4)
London Exchange · UK · prices in USD · close of 21 Oct 2026
Key indicators
| Last close | USD 78.96 |
|---|---|
| 52-week range | 54.12 – 95.18 |
| Return, 1 month / 3 months | −4.7% / −5.7% |
| Return, 1 year / 3 years | +31.2% / +120.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 46 |
| Volatility (1 year) | 38.7% |
| Worst drawdown (1 year) | -23.1% |
| Average daily value traded | 0.35M USD |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Delta Air Lines is an American airline based in Atlanta, Georgia. It carries passengers on scheduled flights across a domestic network in the United States and on international routes to destinations in Europe, Latin America, Asia and elsewhere. The airline serves business and leisure travellers, offering cabins from basic economy through premium classes, and it runs a frequent flyer programme. Delta also operates cargo services and maintenance operations, and it works with partner airlines on connecting journeys around the world.
The shares are listed on the London Exchange in UK under the code 0QZ4, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Delta Air Lines Inc. (0QZ4) trades on the London Exchange in UK. It last closed at USD 78.96 on 21 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 1,827 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 31.2% and over the last three months it fell 5.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.9% | ||
| From 52-week high | -15.5% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.7% | ||
| 6-month return | 11.3% | ||
| 12-month return, skipping the last month | 37.7% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 38.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.1% | ||
| Liquidity | 42 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.35M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 29 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.5% |
|---|---|
| 1 month | −4.7% |
| 3 months | −5.7% |
| 6 months | +11.3% |
| 1 year | +31.2% |
| 3 years | +120.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 81.56 / 75.97 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Oct 2026 | USD 0.2150 |
| 8 Jul 2026 | USD 0.2150 |
| 14 May 2026 | USD 0.1875 |
| 25 Feb 2026 | USD 0.1875 |
| 15 Oct 2025 | USD 0.1875 |
| 30 Jul 2025 | USD 0.1875 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.